Top Markets
Coin of the day
Anbio Biotechnology Class A Ordinary Shares Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology Class A Ordinary Shares

NNNN
Rank in Stocks #16102
Anbio Biotechnology, established in 2021 and based in Frankfurt am Main,... Anbio Biotechnology, established in 2021 and based in Frankfurt am Main, Germany, operates as a global supplier of in vitro diagnostics (IVD) products. The company's international footprint covers regions such as the European Union, Asia Pacific, North America, South America, and Africa. Their product range features various diagnostic solutions, including rapid antigen tests for SARS-CoV-2 (both individual and combined with influenza A/B). Anbio also develops and manufactures products leveraging advanced technologies like lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification (LAMP), chemiluminescence immunoassay (CLIA), and reverse-transcription polymerase chain reaction (RT-PCR). These offerings cater to a wide array of markets, including over-the-counter sales, point-of-care testing, and traditional laboratory settings.
Share Price
$7.15
Market Cap
$313.60M
Change (1 day)
-2.12%
Change (1 year)
-84.14%
Country
DE
Trade Anbio Biotechnology Class A Ordinary Shares (NNNN)

Category

Stock split history for Anbio Biotechnology Class A Ordinary Shares (NNNN)
Anbio Biotechnology Class A Ordinary Shares stock (symbol: NNNN) underwent a total of 0 stock splits.
The most recent stock split occurred on Sep 01, 2026.
One NNNN share bought prior to Sep 01, 2026 would equal to 0 NNNN shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
3 x4
US
3 x20
FR
0 -
JP
6 x20
US
0 -
CH